SEC Form 4 · accession 0001746822-26-000005
Bionano Genomics, Inc. · BNGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Luderer
Officer — Interim Chief Executive · Director
Period of report
Sep 4, 2026
Accepted (ET)
Sep 9, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001411690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 4, 2026 | P | 4,000 | $1.2112 | A | 8,000 | I | Traditional IRA |
Table II — derivative securities
No Table II lines on this filing.